The views and opinions expressed herein are those of the authors and do not necessarily reflect the views of LGBR and its affiliates or employees. The information set forth herein has been obtained or derived from sources believed by the authors to be reliable. LGBR does not make any representation or warranty, express or implied, as to the information's accuracy or completeness, nor does the author recommend that the attached information serve as the basis of any investment decision and it has been provided to you solely for informational purposes only and does not constitute an offer or solicitation of an offer, or any advice or recommendation, to purchase any securities or other financial instruments, and may not be construed as such.

News/Blog

16 Jan 2018

Professional Adviser: LGBR Tax-efficient series a ‘must attend event for advisers’

Tax-efficient investment specialists Unicorn Asset Management, Maven Capital Partners, Triple Point and Seneca Partners are all speaking at LGBR’s EIS, VCT and IHT Forums, which will visit Harrogate, Manchester, Solihull and London (twice) between 25 January and 21 February 2018. To register or find out more, please click here. For more information LGBR’s range of tax efficient products, please click here or call on 020 3195 […]

Tax-efficient investment specialists Unicorn Asset ManagementMaven Capital PartnersTriple Point and Seneca Partners are all speaking at LGBR’s EIS, VCT and IHT Forums, which will visit Harrogate, Manchester, Solihull and London (twice) between 25 January and 21 February 2018.

To register or find out more, please click here.

For more information LGBR’s range of tax efficient products, please click here or call on 020 3195 7100.

 

Read More
21 Dec 2017

Jack Rose: A round-up of the tax efficient year

The build-up to and subsequent outcome of the Patient Capital Review were major talking points for the tax-efficient space and, writes Jack Rose, its implementation and impact look set to be similar in the year ahead. Click here to read the full article. For more information LGBR’s range of tax efficient products, please click here or call […]

The build-up to and subsequent outcome of the Patient Capital Review were major talking points for the tax-efficient space and, writes Jack Rose, its implementation and impact look set to be similar in the year ahead.

Click here to read the full article.

For more information LGBR’s range of tax efficient products, please click here or call on 020 3195 7100.

Read More
8 Dec 2017

Maven VCT Conference Call Recording – New £30m joint offer

Click here for the recording of yesterdays Maven VCT call with manager Bill Nixon. For more information about the conference call or LGBR Capital’s range of tax efficient products, please click here or call on 020 3195 7100.  

Click here for the recording of yesterdays Maven VCT call with manager Bill Nixon.

For more information about the conference call or LGBR Capital’s range of tax efficient products, please click here or call on 020 3195 7100.

 

Read More
5 Dec 2017

Unicorn win Best Aim-Based VCT

Congratulations to Unicorn who’s excellence in the field was recognised last week at the second iteration of the Investment Week Tax Efficiency Awards where they collected the award for the Best Aim-Based VCT. Click here to read the full article. For more information about LGBR Capital’s range of tax efficient products, please click here or call 020 3195 7100. 

Congratulations to Unicorn who’s excellence in the field was recognised last week at the second iteration of the Investment Week Tax Efficiency Awards where they collected the award for the Best Aim-Based VCT.

Click here to read the full article.

For more information about LGBR Capital’s range of tax efficient products, please click here or call 020 3195 7100. 

IWTEA17-LOGO-WIN-Best Aim-Based-VCTs

Read More
5 Dec 2017

LGBR win two awards at Investment Week Tax Efficiency Awards

We are delighted to announce that last week LGBR Tax won two awards at the 2017/18 Investment Week Tax Efficiency Awards. LGBR collected the Education Initiative of the Year award, and jointly shared the Tax -Efficient Group of the Year award. Click here to read the full article. For more information about LGBR Capital’s range of tax […]

We are delighted to announce that last week LGBR Tax won two awards at the 2017/18 Investment Week Tax Efficiency Awards.

LGBR collected the Education Initiative of the Year award, and jointly shared the Tax -Efficient Group of the Year award.

Click here to read the full article.

For more information about LGBR Capital’s range of tax efficient products, please click here or call 020 3195 7100. 

IWTEA17-LOGO-WIN-Tax-Efficient Group of the YearIWTEA17-LOGO-WIN-Education Initiative of the Year

Read More
30 Nov 2017

Ian Battersby: EIS life beyond the Budget

Ian Battersby of Seneca Partners offers his thoughts on the EIS market in the run-up to the tax year-end, the potential impact of changes announced in the Budget and the proposals outlined in the much-anticipated Patient Capital Review. Click here to read the article in full. For more information about the conference call or LGBR Capital’s […]

Ian Battersby of Seneca Partners offers his thoughts on the EIS market in the run-up to the tax year-end, the potential impact of changes announced in the Budget and the proposals outlined in the much-anticipated Patient Capital Review.

Click here to read the article in full.

For more information about the conference call or LGBR Capital’s range of tax efficient products, please click here or call 020 3195 7100. 

 

Read More
24 Nov 2017

Jack Rose: The Patient Capital Review reviewed

Budget implications for EIS & VCT: Jack Rose, Head of Tax Efficient Investment at LGBR Capital, writes in investment week looking at the implications that the changes in the Budget would have on tax efficient products. Click here to read the article in full  For more information about the conference call or LGBR Capital’s range of […]

Budget implications for EIS & VCT: Jack Rose, Head of Tax Efficient Investment at LGBR Capital, writes in investment week looking at the implications that the changes in the Budget would have on tax efficient products.

Click here to read the article in full

 For more information about the conference call or LGBR Capital’s range of tax efficient products, please click here or call on 020 3195 7100.

Read More
23 Nov 2017

Patient Capital Review Outcome – Conference Call Recording

Following the outcome of the Patient Capital Review in this weeks budget, Head of Tax Efficient Investment at LGBR Capital, Jack Rose, hosted a conference call this morning to look at the implications and effects that they changes would have on tax efficient products. Listen to the conference call here:   For more information about […]

Following the outcome of the Patient Capital Review in this weeks budget, Head of Tax Efficient Investment at LGBR Capital, Jack Rose, hosted a conference call this morning to look at the implications and effects that they changes would have on tax efficient products.

Listen to the conference call here:

 

For more information about the conference call or LGBR Capital’s range of tax efficient products, please reply to this email or call me on 020 3195 7100.

Read More
22 Nov 2017

Jack Rose: All you need to know about potential Patient Capital Review changes

Ahead of the release of the Patient Capital Review today, head of the tax-efficient division at LGBR Capital, Jack Rose gives his view on what could be in store for VCT or EIS tax reliefs. Click here to read the full Investment Week Article. For more information on any of the tax efficient products we […]

Ahead of the release of the Patient Capital Review today, head of the tax-efficient division at LGBR Capital, Jack Rose gives his view on what could be in store for VCT or EIS tax reliefs.

Click here to read the full Investment Week Article.

For more information on any of the tax efficient products we distribute click here or call us on 020 3195 7100.

Read More
2 Nov 2017

Unicorn AIM IHT/ISA Update with Chris Hutchinson

Chris Hutchinson, manager of the Unicorn AIM IHT/ISA Portfolio Service shares his update on the service since launch, where he continues to find value in AIM and the potential risks of following the pack when it comes to investing in the successful junior index.   To find out more about the Service, please click here or call our […]

Chris Hutchinson, manager of the Unicorn AIM IHT/ISA Portfolio Service shares his update on the service since launch, where he continues to find value in AIM and the potential risks of following the pack when it comes to investing in the successful junior index.

 

To find out more about the Service, please click here or call our team on 020 7071 3940.

Read More
1 2 3 11

Get in Touch

Please do not hesitate to get in touch for further information on LGBR or on the investment products we distribute.

Disclaimer

In order to view the information on the LGBR Tax website (www.lgbrtax.com) (the "Website"), you must accept the terms and conditions set out below (these "Terms") and our separate Terms of Use. These Terms create a binding legal agreement between us. For your own protection and benefit, please read these Terms carefully before starting to use this section of the Website. During each visit to this section of the Website, you are responsible for being familiar with, and are bound by, the then current version of these Terms. If you do not agree to these Terms, please refrain from using the Website. By clicking "Accept" below and accessing the information and material available on the Website, you accept these Terms.

IMPORTANT NOTICE: For legal reasons the contents of the Website cannot be made available to US residents. These materials and any products described herein are not being offered or targeted to US persons or to US residents and access by them is prohibited.

This section is only for UK regulated financial advisers, wealth managers and others regulated by the Financial Conduct Authority.
This section is not intended for, and must not be accessed by, investors who would be classified as retail clients under MiFID. If you are in any doubt as to whether you would be deemed to be a 'professional client' or 'eligible counterparty', please seek professional advice and refrain from accessing this section until such advice has been obtained.

By clicking 'I accept' you confirm that you are an FCA authorised financial intermediary, you also confirm that:
(i) you are eligible to access this section of the website and that you are acting on the behalf of your client as their authorised adviser or are seeking information as a representative of an institution;
(ii) you understand that the information contained in this section of the website is provided solely for the use by the advisers of organisations or representatives of such organisations, and not for members of the general public;

I confirm that:

  • I have read and accept the Terms and Conditions of using this Website, detailed above;
  • I am a professional client or eligible counterparty for the purposes of the Conduct of Business Sourcebook of the FCA;
  • I will not make an investment in an Investment Product, or advise another to do so, if the promotion of the Investment Product to the type of investor I represent is prohibited;
  • I recognise that the information provided on this Website is for information purposes only and is not a solicitation of an investment;
  • I will study the Prospectus, KIID or Offering Memorandum of an Investment Product, including the risk factors before making an investment